Collegium Pharmaceutical, Inc
Collegium Pharmaceutical develops and commercializes products for ADHD and moderate to severe pain, including Jornay PM (methylphenidate for ADHD), Belbuca (buprenorphine buccal film), Xtampza ER, and Nucynta products (tapentadol formulations).
424B3Sep 11Latest SEC filing
Sep 24Latest story
September 2026
August 2026